mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.06 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.07 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.07 |